Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about ALXOncology-2020-12-09
$208.0 Million
Image
ALX Oncology
Follow-On Offering
Active Bookrunner
Read more
about RocketPharmaceuticalsInc-2020-12-09
$299.0 Million
Image
Rocket Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about SutroBiopharmaInc-2020-12-08
$145.0 Million
Image
Sutro Biopharma, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CogentBiosciences-2020-12-01
$115.0 Million
Image
Cogent Biosciences
Follow-On Offering
Active Bookrunner
Read more
about ProtagonistTherapeuticsInc-2020-12-10
$115.0 Million
Image
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about KerosTherapeutics-2020-11-17
$149.5 Million
Image
Keros Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about AptinyxInc-2020-10-21
$48.3 Million
Image
Aptinyx Inc.
Follow-On Offering
Active Bookrunner
Read more
about IMabBiopharma-2021-02-08
$203.9 Million
Image
I-Mab Biopharma
Follow-On Offering
Active Bookrunner
Read more
about SeresTherapeuticsInc-2020-08-12
$225.8 Million
Image
Seres Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about AdverumBiotechnologiesInc-2020-08-12
$216.8 Million
Image
Adverum Biotechnologies, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 19
Next page
››
Subscribe to Active Bookrunner
